IV
Laboratory methods for the detection of respiratory viruses allow for not only the identification, but also the exclusion of a specific etiology underlying a given pathogenic state of the respiratory system. They complement and support the clinical diagnosis and provide a basis for clinical decision making and further treatment. They are also useful for epidemiologic studies. Like all viruses, respiratory viruses can be detected by one or a combination of the three major viral detection methods:
• Direct detection of the virus or its genetic material or proteins • Culture of the virus in a suitable host or cell line and assessment of its presence and effects on the host or cell line • Serologic evidence of infection in the organism Direct detection methods include detection of whole viruses with electron microscopy and detection of inclusion bodies by light microscopy. In addition, a virus can be detected by means of specific antibodies against its antigens, either in body fluids or after its culture in host cells. Polymerase chain reaction (PCR) seems to be the most powerful of the molecular biologic techniques used to detect viral genetic material directly. A recent development of this technique, real-time PCR, also allows calculation of the number of copies of the virus present in a given biologic sample.
Culture of a respiratory virus in a host allows both its direct detection, as described earlier, and its indirect detection, based on the biologic effects it may trigger in the host. Thus, respiratory viruses can be detected and titrated from the cytopathic effect (CPE) that they trigger in cultured cells; for example, orthomyxoviruses and paramyxoviruses, such as influenza and parainfluenza, can be detected by their ability to trigger erythrocytes to aggregate (hemagglutination).
Serologic studies can be used in many ways for virus detection. In one approach, the presence of specific antibodies in the organism can lead to inhibition of a biologic effect that a stock viral solution elicits in target cells (e.g., inhibition of hemagglutination). In addition, the ability to assess immunoglobulin M (IgM)-specific antibodies in the patient's blood during the acute phase or changes in immunoglobulin G (IgG) antibody titers between the acute phase and convalescence is a valuable tool that can identify ongoing viral infection and, in some cases, discriminate between recurrent and latent infection.
■ BRIEF OVERVIEW OF VIRUSES INVOLVED IN RESPIRATORY ILLNESS
Viral agents with a tropism for the respiratory system infect or produce symptoms in both the upper and lower airways. Although it is frequently mentioned that hundreds of different viruses can produce respiratory symptoms, this is due to the large number of picornavirus (>150) and adenovirus (>50) serotypes. Because there are small differences in clinical presentation between these serotypes, seven to eight types of agents can be described separately. , including the newly identified NL63 and severe acute respiratory syndrome (SARS) coronaviruses and the also recently identified human metapneumovirus (MPV). The most prevalent pathogenic microorganisms are probably human RVs. These "common cold" viruses belong to the picornavirus (small RNA) family, which also includes the enteroviruses, such as poliovirus, echovirus, and Coxsackie virus, and cardiovirus and aphthovirus. More than 100 RV serotypes have been identified and numbered. These are divided into major (90% of serotypes) and minor groups; the former use intercellular adhesion molecule-1 as their cellular receptor, whereas the latter use the low-density lipoprotein receptor. The epidemiology of RV-induced colds is closely related to social contact, and peaks are usually seen when children return to school after a vacation period. One of the most prominent roles of RV is in triggering asthma exacerbations. 1 Comparative titrations of nasal, pharyngeal, and oral secretions have shown that replication is more active in the nose. However, studies comparing nasal and throat swabs with sputum samples obtained during asthma exacerbations showed that the viral isolation rate was higher in sputum, suggesting that RVs may also replicate in the lower airway. This was later clearly demonstrated with the use of molecular biology-based detection techniques. 2 Although the severity of upper respiratory tract symptoms after RV infection does not differ between patients with asthma and normal subjects, both the duration and the severity of lower respiratory tract symptoms are more pronounced in patients with asthma. 3 The lower respiratory tract epithelial cells infected by RVs are rich sources of inflammatory mediators that may trigger or propagate airway inflammation and obstruction.
Respiratory syncytial virus belongs to the Pneumovirinae subfamily and is a medium-sized (100-300 nm) RNA virus. Variations in the attachment glycoprotein of the viral envelope give rise to the two antigenically distinct strains of RSV, A and B. Although there have been conflicting data, the majority of studies report that A strains are more common and produce more severe disease. A wide range of species can be experimentally infected with human RSV, but natural infection is species-specific. RSV enters the body through the eye or nose and, to a lesser extent, through the mouth. The virus subsequently spreads along the airway mucosa, mostly by cell-to-cell transfer along intracytoplasmic bridges, and also through aspiration from the upper to the lower airway. RSV follows a well-characterized epidemiologic pattern, with yearly outbreaks occurring between October and May in temperate climates. At least half of the infant population becomes infected during their first RSV epidemic, and almost all children have been infected by 2 years of age. Although infection usually leads to mild respiratory illness, some infants have more severe disease. Bronchiolitis is the characteristic clinical manifestation of such a complication. There is evidence that hospitalizations for bronchiolitis have considerably increased during recent decades and that hospitalized children have increased probability of wheezing later in life, 4 with the immune status of the host probably playing an important role in the process. 5 The relationship between RSV infection, atopy, subsequent symptoms, and the development of asthma is discussed in detail in Chapter 55.
Three types of influenza viruses, designated A, B, and C, and belonging to the orthomyxoviruses, have been identified. They are negative-stranded segmented RNA viruses. The two influenza envelope glycoproteins hemagglutinin and neuraminidase determine both viral entry into target cells, by binding to sialic acids and fusing with cellular membrane elements, and the release of the virus. Infection with influenza virus occurs by inspiration of contaminated droplets from infected persons. Infected cells become round and swollen with pyknotic nuclei. Edema and polymorphonuclear infiltration are seen in the surrounding tissues. The progressive changes in epithelial cells suggest that infection starts in the trachea and then ascends or descends. The epidemiology of influenza viruses is characterized by yearly epidemics lasting for 6 to 8 weeks during late winter; each year, there is usually only one dominant type or subtype. Illnesses initially appear in children, whereas later in the epidemic, more adults are affected. Viruses are present in the community before and after the epidemic, causing illness at a low frequency. Antigenic variation readily occurs in H and N primary structures, giving rise to new subtypes (antigenic shift) and to intrasubtype changes (antigenic drift). Only type A influenza viruses have been associated with pandemics that have been occurring every 10 to 40 years. The last potentially pandemic strains to emerge were recorded in 1997 and 2003, and were of avian origin. 6 The currently circulating type A human isolates are H1N1 and H3N2 subtypes. The avian isolates were of H5N1 and H7N7 subtypes and were able to be transmitted to and infect humans 7 by entering the cells through different cellular receptors. 8 Human parainfluenza viruses (PIVs) include four members, numbered 1 to 4, and belong to the Paramyxoviridae subfamily, together with mumps and measles. Each PIV has distinct epidemiologic and clinical characteristics, as well as different age distribution patterns. PIV 1 and PIV 2, members of the Respirovirus genus, are generally associated with laryngotracheobronchitis (croup), upper respiratory tract illness, and pharyngitis, whereas PIV 3, a member of the Rubulavirus genus, is also a major cause of infant bronchiolitis and is associated with the development of pneumonia in susceptible subjects. PIV 4 is rare and less well studied. PIV 1 occurs in biennial epidemics during autumn, coinciding with croup outbreaks; its peak incidence occurs in children 2 to 3 years of age. PIV 2 epidemics are less predictable; however, they more or less follow the biennial pattern of PIV 1, affecting mostly children younger than 5 years of age. PIV 3 is unique among PIVs in its propensity to infect infants younger than 6 months of age in spring epidemics. PIV 3 infections are more frequent and occur yearly, with peaks seen during spring and summer. Infection is initiated by attachment of the virus to the host cell through interaction of the viral H and N glycoproteins with cellular sialic acid receptors, followed by uncoating of the virus, its translocation into the cytoplasm, and transcription, leading to replication. For transmission, aerosol spread is considered important, although deposition on surfaces and subsequent self-inoculation may also be relevant. Virus replication can occur throughout the tracheobronchial tree, causing local inflammation; however, only mild and rapidly repaired focal tissue destruction is observed in vivo. However, in immunocompromised hosts, fatal giant cell pneumonia may develop. Central to the pathogenesis of PIV infection is the ability of these viruses to escape interferon-mediated immune responses. 9 In contrast to the rest of the respiratory viruses, adenoviruses are deoxyribonucleic acid (DNA) viruses. This large family of viruses includes six subgenera and more than 50 serotypes. Their overall size is 70 to 90 nm; the virion is naked and contains 36 to 38 kb double-stranded DNA, encoding more than 50 polypeptides from both strands. Some of these proteins allow efficient endosomal lysis and escape, leading to genome entrance into the host cell nucleus. The propensity of adenoviruses to shut off the expression of host messenger RNA and induce excess synthesis of adenoviral proteins leads to an accumulation of such proteins as intranuclear bodies, which are incompatible with normal cell function. In upper airway epithelial cells, ciliary and microtubular abnormalities lead to defective mucociliary clearance. An important feature of adenovirus is its ability to persist in the host for a long time, through low-grade replication, or for even longer periods, with production of adenoviral proteins without replication of a complete virus.
Human coronaviruses were isolated during the mid-1960s. The majority of HCVs studied to date are related to one of two reference strains, designated OC43 and 229E, which differ extensively. Recently, coronavirus NL63 was isolated from an infant with bronchiolitis and conjunctivitis. 10 It shares 65% sequence identity with 229E, but several prominent differences indicate that NL63 is a new group I coronavirus. Human aminopeptidase N, which is present on lung, intestinal, and kidney epithelial cells, has been identified as a receptor for HCV-229E. OC43 binds to major histocompatibility complex class I molecules. Viral replication has been demonstrated in the nasal mucosa, inducing inflammation, ciliary damage, and epithelial cell shedding. Its in vivo CPE is not pronounced, as in the case of RV infections. HCV replication in the lower airway has not been confirmed. Volunteers can be successfully infected by intranasal inoculation. HCV causes approximately 15% of common colds. The disease is generally mild, and there is evidence that HCV-induced colds may cause milder lower respiratory tract symptoms than other viruses. However, there have been reports of more severe lower respiratory tract involvement in young children and the elderly.
The recent Eastern Asia-based SARS epidemic has been attributed to a new coronavirus that shares limited homology with the other known coronaviruses. 11 The virus causes diffuse alveolar damage, with interstitial infiltrates. After 3 to 7 days of fever, a nonproductive cough may progress to breathlessness and hypoxemia in 15% of patients. This serious infection is characterized by a 3% to 6% mortality rate (or even as high as 43%-55% when patients older than 60 years of age are considered). 12 In children, the illness is much more mild (see Chapter 33) . Although SARS-CoV is a coronavirus, it differs phylogenetically from all other known HCVs, and there is evidence that it is not derived from any other characterized coronavirus. In addition, sequence of the Tor2 isolate showed a number of distinctive features of its genome (e.g., several small, open reading frames between its genes) that are of potential biologic significance. 13 Finally, a new respiratory virus, MPV, was recently isolated from nasopharyngeal aspirates of young children in the Netherlands, 14 and was later shown to be present worldwide. MPV is the first human respiratory pathogen classified as a member of the Metapneumovirus genus. The new virus proved to have paramyxovirus-like pleomorphic particles on electron microscopy. Phylogenetic analyses showed some sequence variation between isolates and the existence of two potential genetic clusters of MPV. The clinical symptoms of the children from whom the virus was isolated in the Netherlands ranged from upper respiratory airway disease to severe bronchiolitis and pneumonia. 14 Subsequent studies, conducted in different locations and using mixed patient populations with various respiratory symptoms, established the association of this virus with acute respiratory illness in both the upper and lower tracts, and in all age groups. 15, 16 ■ DIAGNOSTIC TECHNIQUES ■ VIRUS CULTURES
Treatment of Clinical Samples
A major prerequisite for the successful application of a detection method is the appropriate collection, transport, and maintenance of the clinical sample. In general, samples collected during the first days of symptoms lead to higher recovery rates of viruses. Upper respiratory samples include nasopharyngeal and oropharyngeal swabs, with the former providing a lower rate of contamination by lower respiratory components. The swabs can then be placed in viral transport medium for further culture or can be used to prepare slides for immunofluorescent detection, either by rolling the swab directly on the slide or after recovery of cells by centrifugation. Nasopharyngeal aspirates (NPAs) are considered better sources for viral isolation than swabs. Although induced sputum is often contaminated by oropharyngeal components and microbial agents that hinder viral recovery, it is an easily obtainable sample, at least in older children, in whom the success rate is greater than 70%. Therefore, it is often used after either filtering through 200-nm membrane filters or dilution, usually in the presence of a reducing agent, such as 0.1% dithiothreitol, to reduce its viscosity. Transtracheal aspirates, bronchial biopsy specimens, and bronchial wash samples are all considered better sources than sputum for both culture and direct immunodetection of viruses in pelleted cells. Similarly, after centrifugation under mild conditions (10 min/500 × g), both the supernatant and the pellet of bronchoalveolar lavage provide good sources for isolation and immunofluorescent detection of respiratory viruses. However, the invasiveness of these procedures precludes their routine use in children. A detailed description of this issue is beyond the scope of this chapter, and a variety of comprehensive articles are available within this textbook and elsewhere.
Cell Culture
For each respiratory virus, there are a number of cell lines and strains that allow its replication in vitro (Table 22- 1) . Susceptible cell cultures may undergo degenerative processes on exposure to respiratory viruses. The most common CPE patterns include syncytia formation (fusion of many cells in multinucleated structures), vacuolation (generation of large, bubble-like regions in the cytoplasm), and granular degeneration. Rounding and detachment are also common features ( Fig. 22-1 ). The dose that causes the CPE in 50% of inoculated wells (TCID 50 ) is used to express the content of a given viral preparation (titer).
When the cell monolayer is permitted to grow covered by a solid (agar) medium, the foci of virus-infected cells form plaques that may be able to be stained by specific dyes (e.g., neutral red) in a manner different from uninfected cells; thus, they can be readily identified and counted. Viruses can also be plaque-purified with this technique.
Viruses that possess hemagglutinins (e.g., influenza and parainfluenza viruses) may be able to adhere to erythrocytes of the host cells in which they replicate. When a suspension of erythrocytes derived from a suitable species is added to the infected cell culture, these adhere in clumps after a certain period, revealing virus.
Rotation enhances both the yield and the effectiveness of the CPE of a cultivated virus. Liposomal and other agents added in the media, as well as centrifugation protocols, may increase the detection rate. In addition, a virus can be isolated by culturing cells derived from a biopsy sample, although coculture with helper cells often leads to higher recovery rates, because this technique overcomes the viral inhibitory activity of certain tissue homogenates.
Cell culture can be used in two additional ways for the identification of respiratory viruses. First, sera from patients can be assessed for the ability to inhibit the CPE, plaque formation, or hemadsorption activity normally triggered by a stock viral solution of known infectivity. Conversely, virus strains isolated from patients can be exposed to specific immune sera known to prevent such activities, and the final result assessed on the cell culture.
Although cell culture remains, in many cases, the gold standard, achieving the highest sensitivity scores in the detection of several viruses, it has the major disadvantage of being a rather time-consuming process, demanding several days or even weeks before some results can be obtained. This is obviously unacceptable in clinical practice, in particular, whenever decisions about, or alterations in, antiviral treatment must be made. Recently, more rapid protocols, using a combination of cell culture with another detection method, such as immunofluorescence, electron microscopy, or PCR-based methods, have been developed. With these techniques, rather than monitoring the appearance of CPE, the sample is inoculated onto the culture and the presence of replicating virus is verified after 24 to 48 hours by the second method.
Mixtures of cell lines have also been used to improve detection rates. In an interesting recent advance, influenza-susceptible, mink-lung-derived Mv1Lu cells and the human adenocarcinoma A549 cell line were used in combination to detect respiratory viruses. Coculture of these two cell lines in shell vials has been shown to detect respiratory viruses synergistically, with greater sensitivity than single cultures. The R-mix monolayers that can be used directly from cryopreserved vials are inoculated on coverslips with the clinical sample, and the vial is centrifuged at 700 × g for 60 minutes. Serum-free medium is added, and 24 hours later, the coverslip is removed and stained with a mixture of antisera against many respiratory viruses. If a positive signal is present, cells from a parallel coverslip can be dispersed onto a suitable chamber containing multiple coverslips that can be examined separately for the presence of individual respiratory viruses using monoclonal antibodies. Using this method, definitive results (positive and negative) can be obtained within 2 days, 17 whereas in conventional, single-cell-culture CPE observation, the final result takes approximately 10 days; moreover, positive results can be obtained up to 4 days earlier with this method. Although of similar sensitivity to conventional cell culture and direct immunofluorescence with respect to most respiratory viruses (influenza, parainfluenza, and RSV), this method is less sensitive in detecting adenovirus; RV has not been tested so far. 18
Eggs
Fertile eggs are used for the culture of respiratory viruses, such as influenza. Inoculation into the amniotic cavity is used mainly for the isolation of such viruses from clinical samples. Harvesting is usually conducted 48 to 72 hours after inoculation. The eggs should have been previously chilled to prevent the release of red blood cells, which would lead to loss of virus due to absorption to the cells.
Animals
Inoculation of a susceptible animal is a common practice for the detection of many viruses. In the recent SARS epidemics, for instance, one of the first crucial tests to identify the virus was intracranial and intraperitoneal injection of clinical samples into suckling mice, with observation of the mice for 14 days for pathologic findings. 11 Other examples include AdV serotype 5, which, when given intravenously to adult mice, kills them within 3 to 4 days, whereas other adenoviruses, when administered subcutaneously to newborn hamsters, cause their death within 4 to 12 days.
■ DETECTION OF WHOLE VIRUSES BY ELECTRON MICROSCOPY
Nasopharyngeal aspirates and lavages, as well as lung biopsy specimens, are suitable material for the detection of respiratory viruses by electron microscopy.
■ 
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Fluid Samples
In a typical protocol, a 300-or 400-mesh grid is placed on a drop of sample for 5 to 15 minutes. After it is drained with filter paper, the grid can be stained. Fluid samples should be placed on support films on the grid. Films made from 0.3% to 0.5% polyvinyl formal in ethylene dichloride (Formvar solution) are mechanically stronger than collodion films (2% solution in isoamyl acetate). The films are cast on a glass slide by experienced personnel, and grids are made by pressing the grid onto the film slide appropriately in the presence of water. A silver-gray rather than charcoal-gray or gold color coincides with optimal film thickness, and additional carbon coating under vacuum facilitates spreading of the sample, improving the results. Glow discharging under the vacuum or treatment of the grids with a suitable agent (e.g., poly-L-lysine, Alcian blue, cytochrome C, or bovine serum albumin) is commonly used to overcome spreading problems.
No viral transport medium should be added to NPA or bronchoalveolar lavage specimens before electron microscopy because it includes salts and proteins that may obscure the electron microscopy field; in addition, it dilutes the particles. In contrast, concentration of particles contained in lavage and NPA samples is recommended. This can be achieved with ultracentrifugation, ultrafiltration, or agar diffusion. With agar diffusion, a drop of suspension is placed on top of 2% agar and allowed to diffuse freely. At the end of this procedure, liquid and salts are diffused into the agar, leaving a film-coated grid containing the virus that can be drained on filter paper and stained for electron microscopy. The pseudoreplica technique is a variation of the agar diffusion method, whereby the drop is allowed to diffuse into the agar, irradiated, and covered by Formvar film. Then the Formvar membrane is carefully removed and allowed to float onto a water surface. Grids are then applied on the replica membrane and picked up with the aid of filter paper.
Antibodies are also used for the concentration of viruses in suspension (clumping), as well as their attachment onto grids. For aggregation, the samples can be incubated with the antiserum, centrifuged, and placed onto grids with the pseudoreplica technique; alternatively, antiserum is mixed with agar, and a grid is placed onto the gel. Then virus suspension is added and allowed to absorb, followed by removal and staining of the grid. In solid-phase immunoelectron microscopy, the film is coated with antibodies before incubation with virus suspension.
Immunoprecipitation techniques are particularly helpful when picornaviruses are to be detected. These viruses are so small that they sometimes appear similar to lipid droplets. In addition, these techniques allow the specific identification of virus in a biologic fluid, provided that the viral etiology of the pathogenic state under investigation is suspected or known; however, some viruses tend to clump in the absence of antiserum, reducing the specificity of this procedure. Viruses in suspension or on grids can be incubated with primary antiserum, allowed to aggregate, and after the antibody has been washed out, the preparation can be treated with a colloidal gold-labeled secondary antibody. Gold labeling has been used specifically to detect immune complexes in serum, as well as subviral particles. In a somewhat different approach, viruses are exposed to excess antibodies, resulting in extensive coating rather than aggregation of the viruses. This method allows specific identification and serotyping of viruses and can serve to assess the reactivity of convalescent serum against known viruses.
Finally, short-term culture of virus in vitro, if possible, with harvesting before the appearance of the CPE, is a good alternative for the enrichment of a sample that contains unacceptably low numbers of viral particles for electron microscopy. Adenoviruses and paramyxoviruses belong to the group of viruses that can be detected in supernatants before a massive CPE occurs. On the other hand, adenovirus is membrane-associated and may be lost on removal of the debris with centrifugation.
An additional problem with NPA specimens is the presence of mucus, which inhibits spreading of the samples. These specimens can be treated with an equal volume of a buffer containing an appropriate dithiothreitol concentration to break down the mucus.
Biopsy Specimens
Specimens should be placed in 2% to 5% glutaraldehyde in cacodylate or phosphate buffer and stored in a refrigerator at -20 o C, rather than frozen, to maintain the tissue architecture and specifically localize the virus. Osmium fixation (1%-2% OsO 4 in a 4-[2-hydroxyethyl]-1-piperazineethanesulfonic acid [HEPES]-or a piperazine diethanesulfonic acid [PIPES]-based buffer) is also used. En bloc staining can then be conducted with uranyl acetate in veronal buffer. Otherwise, dehydration and embedding in resins should follow the fixation step. Although it is not optimal, formalin-fixed material and paraffin-embedded sections can also be used for electron microscopy, under some circumstances, after suitable treatment. Because the sample area used for electron microscopy is limited, it is wise first to stain sections with suitable stains, such as toluidine blue; to select areas of particular interest (e.g., those with a CPE); and to trim the sections further for thin sectioning. Viruses can also be seen by extracting solid tissue with a suitable buffer, after homogenization or repeated freezing and thawing and further treatment as a liquid sample. Thin sectioning is also the method of choice for identification of virus in cell culture. If the virus has triggered cell lysis, it can be detected in cell supernatant or medium, after ultracentrifugation is performed to remove the debris, followed by negative staining of the pellet. Cells can also be embedded in agar and further treated as tissue blocks.
Electron Microscopic Appearance of Respiratory Viruses
Electron microscopy of liquid samples containing respiratory viruses aims to identify particles based on their morphologic characteristics ( Table 22 -2). Picornaviruses and adenoviruses are the two types of respiratory viruses with naked virions of icosahedral symmetry; they have a round appearance on electron microscopy. In contrast to adenoviruses, which have the higher size ranges among naked virions, picornaviruses are very small, and can be often confused with some tail-less bacteriophage species. If available, immunoprecipitation techniques can be used in such cases, and clumping, coating, or concentration of spherical structures is a prerequisite for a given sample to be characterized as positive. In addition, adenoviruses can degenerate, and individual capsomers may appear separately, forming hexagonal lattices. Adenoviruses also resemble herpesviruses in appearance, and differentiation may be based on the larger size of the latter. Enveloped respiratory viruses, such as influenza viruses, parainfluenza viruses, and coronaviruses, have a soft membrane that can become deformed during drying for negative staining. Thus, the particles may appear pleomorphic, and may vary in size. The enveloped respiratory viruses are spiked, rather than smooth. Coronaviruses have long (20-nm) spikes on the surface, whereas paramyxoviruses and orthomyxoviruses contain projections that appear as a fringe on the outer side. However, even these forms can sometimes be confused with mitochondria or inverted bacterial membrane debris. Finally, a major problem with the orthomyxovirus and paramyxovirus families is that they have a similar electron microscopic appearance, and additional information is usually required to discriminate between them.
Another feature that may facilitate the identification of a particular respiratory virus is the appearance of the nucleocapsid. This structure is present in enveloped viruses and contains the nucleic acids and some viral proteins. It can be spherical, helical, or complex. Parainfluenza viruses, for instance, have helical filamentous nucleocapsids.
Information obtained from electron microscopic study of thin sections of solid tissues is not limited to the appearance of viral particles. The cellular location also provides important evidence of their properties. For instance, viruses replicating in the nucleus are DNA viruses, whereas RNA viruses replicate in the cytoplasm. Naked viruses, such as adenoviruses, cause cell lysis and can be seen as round shells with a core of different density surrounded by dead cells. If the cytopathology is advanced, adenoviruses may be seen in both the nucleus and the cytoplasm. Picornaviruses cause swelling of the endoplasmic reticulum, and the ribosomes may appear as large beads on a string. Enveloped viruses acquire their membranes by budding through the nuclear envelope, through the plasma membrane, or into vesicles within the cells. There are some difficulties in discriminating virions from normal cell organelles, such as lysosomes and Golgi complexes; however, viruses with spikes appear to have a thicker membrane than the cellular compartments. The size and shape of the nucleocapsid are also of importance. In thin sections, spherical nucleocapsids have a round appearance and resemble small, naked virions, whereas those acquiring a filamentous (helical) shape are thin, elongated structures that are seen going into and out of the plane of section. Adenoviruses can be discriminated from the otherwise similar herpesviruses by the smaller size of their nucleocapsid.
Transmission electron microscopy is a method of reference for the identification and measurement of many viruses (e.g., used as an immediate indicator in the outbreak of the recent SARS epidemic). However, it needs specialized and expensive instrumentation and skilled technicians, a fact that does not facilitate its use in smaller laboratories. Moreover, it is unable to discriminate among viruses of the same family or among particular subtypes, and in many cases, an additional method, such as fluorescence, is necessary to overcome this obstacle. In addition, it cannot distinguish between infectious and noninfectious particles, in contrast to culture-based methods. However, even one virus particle can be identified in a sample, whereas other methods (e.g., antigen detection) require a greater number of viral elements.
Other Whole-Virus Detection Methods
Fluorescent dyes can be used to stain a purified virus preparation and allow enumeration of virus in a solution. OliGreen, for instance, a dye that specifically binds to nucleotides, has been successfully used for the enumeration of adenovirus 5, RSV, and influenza A. This method can be performed within 1 hour. 19 To that end, density-gradient-purified virus preparations are incubated with the dye and subjected to analysis in a modified flow cytometer. Although it has not yet been tested in clinical samples, this method provides information about the genome size of the virus. Its measurements have been consistent with data obtained with transmission electron microscopy enumeration of the same viral stocks.
■ ANTIGEN DETECTION
Antigen-based detection methods for respiratory viruses presuppose the knowledge or suspicion that a particular virus is present in the sample and preclude the discovery of unknown viruses. However, these methods are rapid and accurate. These features are of major importance for the surveillance and control of epidemic diseases (e.g., influenza, RSV). Viral antigens can be revealed based on the ability of the antigen to interact with an antibody or to elicit a specific immune response. In addition, specific functional assays, such as hemagglutination tests, assessing the presence of particular proteins that are found in the envelope of orthomyxoviruses and paramyxoviruses, can be conducted to reveal the respective virus. These are described in the section on serologic methods. Sputum and nasal aspirates are considered better than throat swabs for the detection of viruses, such as RSV and influenza, with these methods.
Immunoassays

Immunofluorescence
Immunofluorescence is based on the chemical conjugation of a fluorochrome with an antibody, without compromising either the ability of the fluorochrome to fluoresce or the specificity of the antibody. Fluorescein isothiocyanate and tetramethyl rhodamine isothiocyanate are the most widely used fluorochromes; the former fluoresces yellowish-green, whereas the latter appears reddish-orange. Fluorescein isothiocyanate seems to be more suitable for clinical samples because the background is more often red than green. In addition, red-fluorescing dyes, such as Congo red, can be used to stain all cellular components red ■ 
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DIAGNOSIS OF VIRAL RESPIRATORY ILLNESS: PRACTICAL APPLICATIONS and provide a contrast to the green fluorescence of fluorescein isothiocyanate. A fluorescence microscope is required for the detection of light emitted by excited fluorochrome. In modern fluorescence microscopes with epi-illumination systems, light of selected wavelengths is deflected through the objective to the top surface of the sample. The resulting emitted light is directed through the objective, a dichroic mirror, a barrier filter, and the oculars, to the observer. Each fluorochrome has specific fluorescence characteristics. For instance, fluorescein isothiocyanate absorption is at 495 nm and emission is at 525 nm. With the available interference filters in fluorescence microscopes, 85% of transmitted light is between 400 and 500 nm (i.e., the visible part of the spectrum). Practically, first, the sample should be fixed onto a slide. Thereafter, it is incubated, either with a specific antibody conjugated with a fluorochrome (direct detection) or with a primary specific antibody and thereafter with a secondary antibody raised against the primary one that has been conjugated with the fluorochrome (indirect detection). The first method is less sensitive, but it avoids nonspecific staining of negative samples, as is often seen with the indirect method. However, the generation of primary conjugates for many viruses is laborious and costly, whereas secondary conjugates may be common for several antigens. Incubation times are short for both procedures (30-45 minutes at 37°C), making immunofluorescence an advantageous method for rapid virus detection.
Viral samples can also be detected by immunofluorescence with spin cultures, whereby suitable cell monolayers are grown on coverslips within flat-bottom vials. The sample is then applied on top of the coverslip, and the vial is centrifuged (650-900 × g for 30-60 minutes). This technique facilitates virus entry into the target cells, and 18 to 24 hours later, or longer (depending on the virus), the coverslip is removed, fixed, and stained for immunofluorescence.
Direct and indirect immunofluorescence has been used for the development of a number of rapid tests for the detection of respiratory viruses. These can be accomplished within a few minutes, and they have become very popular due to their rapidity and ease of performance. Usually, a spot or slide containing the sample is prepared for every virus being tested, cytospun, and incubated with the monoclonal antibody. In a recent advance, a single spot can be used for the simultaneous detection of seven respiratory viruses (RSV, influenza A and B, adenovirus, and parainfluenza 1-3 viruses). A rhodamine label is used with the RSV antibody system, whereas fluorescein is used in all other cases. Thus, the development of a reddish-gold color in the spot suggests the presence of RSV particles in the sample, whereas a green color (fluorescein) is followed by a second reaction in another spot to determine which of the other viruses is present. The sensitivity of this method was greatly enhanced by centrifugation and was superior to that of enzyme immunoassay (EIA)-based protocols, but inferior to that of cell culture in that study. 20 Another indirect fluorescence method proved more efficient than cell culture in detecting respiratory viruses in nasopharyngeal swabs. 21 
Radioimmunoassay
There are two types of radioimmunoassays (RIAs). In competitive RIA methods, a known quantity of radioactivity-labeled antigen competes with unlabeled antigen that is added (test sample). The inhibition of binding of labeled antigen depends on the concentration of unlabeled antigen in the clinical sample.
The labeled antigen that is finally bound to antibody is measured and referred to as bound antigen, whereas the unconjugated labeled antigen is referred to as free antigen. To circumvent problems arising from the separation of bound from free antigen in solidphase RIA, the immunoreactant that is used first (antibody or antigen) is immobilized on a solid support. After each step, unwanted reactants can be removed readily by washing. In contrast to the laborious and expensive generation of labeled viral antigens, many of which are labile, noncompetitive RIA methods use labeled antibodies instead of viral antigens. The former are more stable, with more predictable structures and biochemical properties. Noncompetitive RIAs are, therefore, more popular in diagnostic virology. In a technique known as sandwich RIA, unlabeled viral antibodies adsorbed to a solidphase support are allowed to capture viral antigens present in the clinical sample. Then a radiolabeled antibody (indicator antibody) is allowed to bind to the captured viral antigens. This procedure can be either direct or indirect. In the latter case, a primary unlabeled indicator antibody is used initially, followed by incubation with a secondary radiolabeled antibody. In all of these procedures, free antibody is removed after the final incubation and bound iodine-125-labeled antibody is measured.
Nasal aspirates are a suitable source for assessing the presence of respiratory viruses, such as RSV, with RIA. For the direct detection of viruses in tissue or cell culture, 125 I-labeled viral antibody is incubated with the cell monolayers or tissue sections and unbound labeled antibody is removed. The bound radioactivity is then measured. The radioactivity bound to the infected tissue or culture is then compared with the radioactivity bound to uninfected control samples. Ratios exceeding 2:1 are considered positive. In the indirect version of this technique, the sample is first incubated with unlabeled antibody, followed by 125 I-labeled secondary antibody.
Enzyme Immunoassays
As indicated by their name, EIAs are based on the conjugation of suitable enzymes (e.g., horseradish peroxidase, alkaline phosphatase) to antibodies and their subsequent use for the qualitative and quantitative detection of antigens. Enzyme-labeled antibodies are coupled to substrates that give insoluble color products and used to detect viral antigens, directly or indirectly, in tissues or cell cultures in cytoimmunoenzymatic staining. Colored substrates can be observed with the naked eye, with light microscopy, and even with electron microscopy, in the case of electron-dense products. As in the immunofluorescence methods described earlier, infected and control cell monolayers and tissue sections on slides are fixed and incubated directly with enzyme-coupled antibody (or with an uncoupled primary and an enzyme-coupled secondary antibody, in the indirect approach). Unbound enzyme conjugate is removed by washing, and the slides are incubated with enzyme substrates. After development of the colored product, the slides are rinsed, counterstained, and mounted in mounting medium to be observed under a light microscope.
A modification of the indirect approach includes an additional step whereby an antibody raised against the enzyme is incubated with the sample. Because this antibody is also conjugated with enzyme, its sensitivity is greatly enhanced. Both peroxidaseantiperoxidase and alkaline phosphatase-antialkaline phosphatase are being used, and the final reaction products can be either soluble color complexes or insoluble substrates that can be observed with the naked eye, observed with a light microscope, or measured in a spectrophotometer. In a typical peroxidaseantiperoxidase protocol, the sample and control are incubated with rabbit antiviral antibody and subsequently with a secondary antibody raised in a different species (e.g., sheep, goat). Subsequently, the sample is incubated with peroxidase-antiperoxidase raised in rabbit and, finally, with the substrate, followed by a stopping reaction.
Avidin-biotin is another system that is widely used to increase sensitivity in such approaches. The binding reaction between these two molecules is strong, and it occurs independently of the immune reactions in the assay. In a typical avidin-biotin complex protocol, biotin-conjugated primary antibodies are incubated with the samples, and after the unbound antibodies have been washed out, enzyme-conjugated avidin or streptavidin is added. The complex formed is monitored, with the final addition of substrate and mounting of the slide. In the indirect approach, an unlabeled primary antibody is first incubated with the sample, followed by secondary incubation with biotinylated antibody and the biotin-avidin enzyme complex incubation.
To assess the presence of viral antigens quantitatively, heterogenous EIA assays are used in which enzymatic activity is independent of the interaction of the antigen with the enzymeconjugated antibody (or vice versa, if enzyme-conjugated antigen is used). To that end, the unbound enzyme-labeled antibody should be removed and the incubation should be relatively long. Like viral RIA assays, quantitative EIAs use unlabeled antiviral antibody bound to a solid phase (e.g., microtiter plates, cuvettes). Unbound antibody is removed after adsorption, and nonspecific binding sites are blocked by blocking agents, such as bovine serum albumin. After samples are added, unbound material is removed and enzyme-conjugated antibody is added. This antibody binds to antigen captured by solid-phase bound antibody. After removal of unbound material, enzyme substrate is added and the formation of the reaction product is measured. This measurement reflects the amount of enzyme bound to antigen that is retained in the solid phase. Control samples are always included to define the background levels of each modification. Influenza, adenovirus, and RSV can be measured by these methods.
The cassette EIA method is based on the fact that large amounts of antibody can be bound to nitrocellulose, nylon, and other membranes. Such a membrane is attached to a plastic well, and the entire system is attached to a cassette containing a material that can absorb all waste fluid generated during the assay. The antibody and the controls can be dotted or slotted onto the membrane in separate wells. The method offers the advantages of increased sensitivity and reduced time required for its completion. Based on the same principle, numerous variations are used, with different sensitivity scores. The solid phase, for instance, can be substituted by beads coated with antibody. After incubation with the sample, the beads can be transferred to the membranes and the assay can go on as a standard EIA. Alternatively, a classic dot-blot apparatus can be used to place an antibody in dots on the membrane. The additional binding sites on the membrane are then blocked. Samples and controls can then be added as serial dilutions for quantitation, and waste fluids are collected from the associated vacuum system. However, such systems, although able to discriminate between serotypes of the same species (e.g., influenza A vs. B), may not be as sensitive as cell culture or direct immunofluorescence in detecting virus.
Fluoroimmunoassay
In time-resolved fluoroimmunoassay, the unusually long fluorescence decay time of the lanthanide element europium (Eu +3 ) is used to discriminate the fluorescence decay characteristics of europium-conjugated antibodies from the background fluorescence decay of clinical samples. Europium is first chelated with ethylenediaminetetraacetic acid and then conjugated to antibody. In a representative protocol, a microtiter plate or strip is coated with antibody and the remaining binding sites of the plates blocked. The clinical sample is then added simultaneously with the europium-conjugated antibody, and after incubation, the unbound material is washed out. Adenovirus, RSV, influenza virus, and parainfluenza virus have been detected with time-resolved fluoroimmunoassay. There are, however, reports of limited sensitivity of this method in detecting respiratory viruses in clinical samples. 22 
Optical Immunoassay
A recent advance in the field of antigen detection is optical immunoassay technology. This allows direct visual detection of a macromolecule that is bound onto a molecular thin film. This binding will result in an increase in the thickness of the optical surface (silicon wafer film) that will alter the reflected light path and will be perceived as a color change that is observable with the naked eye. Practically, viral-specific antibodies are immobilized on the surface and allowed to capture extracted viral antigens that are placed directly onto the surface and incubated at room temperature for a short period. After addition of a suitable substrate, a positive result appears as a color spot, whereas in the absence of antigens in the sample, the background color remains unchanged. Commercially available tests for influenza virus and RSV can take as little as 15 minutes to be completed and do not require sophisticated laboratory equipment, providing obvious advantages. An influenza-specific optical immunoassay test has been reported to be as good as cell culture in detecting influenza A or B from clinical samples 23 ; however, others found low sensitivity scores with this method compared with those obtained by direct fluorescence or cell culture. 24 
Agglutination Assays
In the latex agglutination assay, antibody-coated nanoparticles from polystyrene, polyacrylamide and other latexes, agarose beads, or colloidal gold agglutinate in the presence of viral antigens. In a typical protocol for respiratory viruses, a clarified and diluted NPA sample is mixed with antibody-coated latex particles on a microscope slide. An agglutination reaction can be readily observed, usually after 10 to 15 minutes. Although these methods are simple and rapid, they are usually characterized by low sensitivity, and many control clinical samples show nonspecific agglutination.
■ SEROLOGIC METHODS
As indicated by the name, serologic methods attempt to detect viruses in the host by assessing the presence of specific antibodies in blood samples. In most cases, during the course of an illness, blood samples should be collected at least twice: in the acute phase and during convalescence. Comparison of the antibody pattern in these two states allows safe demonstration of diagnostically significant active virus. Acute-phase blood should be collected as soon as possible after the onset of disease (no later than 1 week), whereas the convalescent sample should be collected at least 2 weeks after onset. These requirements make serologic testing more relevant for epidemiologic studies than for clinical use, because the long delay before a definite diagnosis is made limits its use in urgent decision making in clinical practice. However, in many cases in which rapid methods of antigen detection are inefficient (e.g., RSV detection in adults), serologic testing is considered a reference method; moreover, it remains the method of choice for archival material; for example, it is as sensitive as PCR in detecting influenza infections. 25 Among the five classes of human immunoglobulins (IgG, IgM, IgA, IgE, and IgD), the four IgG subclasses (IgG1-4) have a longer half-life (22 days) than the others and are associated with long-term protection. In addition, IgG antibodies exert their protective role against infection by triggering complement fixation and improve the specificity of the immune response by binding to the surface of cytotoxic effector cells. Most viruses induce mainly IgG1 and IgG3 responses. IgM antibodies represent approximately one tenth of serum immunoglobulins and are the first to be produced after exposure to a foreign antigen. Secretory IgA constitutes the first line of defense against mucosal viral infections.
On first encounter with the foreign antigen, the IgM class of antibodies is primarily produced, whereas IgG may be produced subsequently and may dominate the later phase of the response. On repeat encounter, memory B cells produce high levels of high-affinity IgG antibodies. When the antigen is localized in the mucosa, the immune response, driven by B cells of the interstitial lymphoid follicles (e.g., tonsils, Peyer's patches) also produces high quantities of IgA.
There are many potential antigens in each virus that may be presented at different time points in the course of infection. The primary antibody response to a virus is typically characterized by early onset of IgM production (peaking at 2 weeks) that declines later, followed by IgG production (reaching a plateau 2 weeks later) that may persist for years. Reinfection may result in overproduction of IgG, together with low or undetectable production of IgM.
Another major issue in antibody measurement is the type of antibodies targeted by the test. Thus, antibodies detected by EIAs may be different from those that confer neutralization activity. Neutralizing antibodies persist after viral infection; their measurement aims to determine vaccine efficacy and is used in epidemiologic studies rather than for the diagnosis of primary infection. Neutralizing antibodies are raised against particular epitopes, usually found on the surface of the virus, and on binding to the virus, render it noninfectious by blocking its attachment to receptors or preventing uncoating of the virus. In tests assessing neutralizing antibody, the serum sample is usually incubated with a viral preparation of known titer, and its ability to inhibit TCID 50 during CPE development in cell culture is assessed. Alternatively, the reduction in the ability of the viral preparation to form plaques can be measured.
There are three main ways to detect respiratory virus in the host serologically. Immunoassays, conducted in a manner similar to that described earlier for the detection of viral antigens, directly measure antibody-virus interaction through the use of labeled reagents. Complement fixation and passive agglutination assays are based on the ability of virus-antibody interactions to interfere with the functions discussed earlier, but do not allow differentiation between antibody classes. Finally, assays, such as hemagglutination inhibition, allow the measurement of particular antibodies that specifically interact with viral surface proteins.
Immunoassays
As in the antigen detection immunoassays described earlier, reporter molecules conjugated with antibodies (or antigens) allow the assessment of virus-antibody interactions. The reporter molecules may fluoresce (immunofluorescence), may have enzymatic activity for color-developing substrates (EIA), or may have radioactivity (RIA).
Immunofluorescence
In immunofluorescence assays, purified hyperimmune animal sera or monoclonal antibodies are labeled with a fluorescent dye (e.g., fluorescein isothiocyanate). In a typical protocol, a serum sample is incubated with virus-infected cells that are fixed on a slide. After unbound material is washed out, the slide can be dried, mounted, and observed under a fluorescence microscope. Streptavidin-biotin and similar systems that are currently used provide greater flexibility and sensitivity in antibody detection. Background fluorescence is a common obstacle in immunofluorescence procedures. In solid-phase fluoroimmunoassay, the viral antigen is immobilized on an opaque solid-phase surface rather than a slide, and fluorescence is measured in a fluorometer, allowing quantitation and automation of the method. However, fluoroimmunoassay instrumentation cannot discriminate between background and positive fluorescence.
Enzyme Immunoassays
Enzyme immunoassays are used to detect and quantitate antibody raised against viral antigens. Antigens are obtained from various sources, such as lysates from virus-infected cells. To that end, cells are washed, resuspended in serum-free medium, and subjected to repeated freeze-thaw cycles. Virus is then clarified with ultracentrifugation, providing a rich source of antigens. Synthetic peptides also may be used for antigen preparation.
For indirect EIA, the antigen is bound to a solid-phase surface, and after incubation with the serum sample, bound antibodies are detected with an anti-human antibody enzyme conjugate. The more abundant IgG antibodies compete for antigens with the other classes and, thus, should have been removed before IgM measurement. Nonspecific binding is common in this method, and impurities present in the antigen preparation may cause false-positive results. Preincubating the sera with uninfected cells may reduce this problem.
To increase the specificity of this method, inhibition, or competitive, EIAs have been used. In this case, serum antibodies are detected by their ability to block the binding of a known antibody conjugate to the antigen. The detector antibody can be added simultaneously, with or after the antigen and the serum sample. False-negative results can be caused, in this case, by serum antibodies that do not compete with the conjugated antibody, but inhibit the ability of the antibody that is being tested to do so.
In the capture EIA method, anti-human immunoglobulin classspecific antibodies are first bound on a solid-phase (capture-phase) surface. After incubation with the serum sample, viral antibodies are bound on the capture phase, together with viral-unrelated antibodies. Viral antigens are added last and subsequently detected with an antigen-specific antibody conjugate. Due to the selective class-specific adsorption in the first step, this method avoids the problems caused by competition between antibody classes, particularly improving IgM detection. On the other hand, low-level IgG detection may be less sensitive due to the presence of large quantities of total IgG antibodies in serum.
Other Immunoassays
When it is necessary to detect low levels of virus-specific antibodies in serum, standard immunoblot techniques (Western blot) can be used. Briefly, the protein content of semipurified virus propagated in cell culture is applied onto a nondenaturing polyacrylamide gel, and after electrophoretic separation, protein bands are transferred to a nitrocellulose or nylon membrane that can be cut into narrow strips and stored in the freezer. Serum samples can be diluted in buffer containing a protein that blocks free binding sites to reduce nonspecific binding, and then incubated with the membrane. After a washing step, bound antibodies are measured with the use of a radioactive or enzyme-labeled conjugate bound to a suitable secondary antibody. In dot immunobinding assays, viral antigens are bound in a dotted membrane. The membrane is then treated so that the potential protein-binding sites remaining in the membrane are blocked. The dots are then covered with small (e.g., 3-mm) strips saturated with the test serum. After a washing step, anti-human IgG conjugated with the appropriate enzyme is added, followed by incubation with the appropriate chromogen substrate. The intensity of the color spots is compared with that produced by the control sera to reveal specific antiviral antibodies. Dot immunobinding assays serve as qualitative rather than quantitative assays and are also subject to problems with nonspecific binding.
In radioimmunoprecipitation assays, antigen-antibody complexes formed after incubation of the serum being tested with viral antigens are cross-linked and immunoprecipitated with protein A or anti-human IgG antibody. The quantity of radioactivity bound in the precipitate can be measured, and is proportional to the concentration of specific antibodies in the serum.
Avidity assays measure the relative degree of dissociation between specific antiviral antibodies and their respective antigens. During maturation of the immune response, the avidity (strength of the combined interaction of an antiserum with a pattern of antigens) of IgG antibodies remains high, whereas their concentration declines. Thus, sera from recent infection are characterized by high-avidity antibodies and sera from reinfection have low-avidity antibodies. Practically, serum is incubated first with antigen bound to a solid-phase surface. The complex is then allowed to dissociate in the presence or absence of urea, and the relative degree of antibody dissociation (ratio of absorbance in the presence of urea to absorbance in the absence of urea) is measured by standard EIA methods.
Finally, three types of methods have been used to specifically measure IgM antibodies that typically are transiently expressed during primary infection and may facilitate its identification. First, in IgG absorption methods, an IgG absorbent (e.g., staphylococcal protein A, streptococcal protein G) is incubated with the serum, and after a centrifugation step, so that IgM antibodies can be measured in the supernatant. These absorbents are believed to be superior to anti-human IgG antibodies for this method, because the latter may also remove some types of IgM. However, staphylococcal protein cannot bind IgG3, and this could interfere with the accuracy of the method because viral antibodies may be significantly represented in this subclass. Streptococcal protein G, on the other hand, binds all IgG subclasses, but not IgM; accordingly, combinations of streptococci and protein A have been used to remove all IgG and IgA from serum samples before IgM measurement. IgA can interfere with IgM measurement, resulting in false-negative findings by competing with IgM for antigenic sites. Second, in one of the early IgM separation methods, rate zonal centrifugation allowed purification of the IgM subclass based on its higher sedimentation coefficient compared with that of the other antibody classes. Gel filtration takes advantage of the higher molecular weight of IgM compared with the other classes (900 vs. 150-400 kd). However, serum lipoproteins and nonspecific cell agglutinins may be fractionated, together with IgM, and could interfere with the assay. Ion-exchange chromatography, based on the differential binding of IgM and IgG classes to anion-exchange resins, has been used, but the IgM yield is relatively low, whereas IgG and IgA may still be present in the IgM fraction after elution from the column. Third, in the popular IgM immunoassays, anti-human IgM-specific antibodies are employed. Indirect immunofluorescence and EIA are the methods typically used for IgM detection. Capture IgM assays show reduced nonspecific binding; in this method, solid-phase, fixed anti-human IgM antibodies separate IgM after incubation with the serum sample. The potential presence of antiviral elements is further detected using labeled viral antigen or unlabeled antigen, followed by a labeled antigen-specific antibody. Detection of antiparainfluenza IgM has been also reported with the use of hemadsorption.
Complement Fixation
Complement fixation systems take advantage of the fact that complement proteins bind, or "fix," to antigen-antibody complexes during the host immune response to a foreign antigen. If this antigen is cell localized, then the deposition of complement elements will cause cell lysis. Complement fixation to IgM is stronger (>1000 times/antibody molecule) than that to IgG. Complement fixation antibodies can be raised against some or all viral proteins. Their titers increase slowly during primary infection, reaching lower levels than antibody titers detected by the other methods. In addition, they decline gradually, making this method less sensitive than others for the detection of viral infection. An additional problem is the interference of some serum elements (heparin, IgG aggregates) with complement formation. In a typical complement fixation assay, the serum sample is incubated with a particular antigen in the presence of a known amount of guinea pig complement. If a specific antibody is present in the serum, the complement will be bound and depleted from the solution. Subsequently, sheep erythrocytes coated with hemolysin (anti-sheep erythrocyte antibody) are added, and their lysis is proportional to the availability of complement proteins that did not react with the specific antibody during the first step. However, complement fixation assays are considered less sensitive than virus isolation and antigen detection methods in revealing the presence of a respiratory virus in patients.
In immune adherence agglutination assay, a rapid and more sensitive variation, aggregation, rather than lysis, of erythrocytes occurs and is measured. In this detection method, complement that is bound to antigen-antibody complexes is allowed to bind to C′3b receptors in human primate erythrocytes. Thus, agglutination of the erythrocytes reveals specific antibodies in the sample.
A simple technique used earlier for the detection of hemagglutinating activity-containing viruses, such as influenza and parainfluenza, is the hemolysis-in-gel test. Erythrocytes from sheep or chicken were first sensitized by coupling to a viral antigen in a chromium chloride solution. After a washing step, the erythrocytes were suspended in an agarose gel containing guinea pig complement. The serum sample was then loaded onto a well in the gel and allowed to diffuse. The presence of antibodies against the virus would lead to the formation of a zone of hemolysis around the well.
Anticomplement antifluorescence is a modified immunofluorescence assay for the detection of complement fixation antibodies. In this assay, complement is added during or after exposure of virus-infected cells to the serum being tested. Any complement that is bound can then be detected with anti-C′3 antibody. Because nonspecifically bound IgG cannot trigger complement fixation, anticomplement antifluorescence assays do not have the common background problems associated with conventional immunofluorescence.
Agglutination Assays
Hemagglutinin or hemagglutinin-neuraminidase proteins expressed in the envelopes of viruses, such as influenza and parainfluenza, are able to bind to specific erythrocyte surface receptors and cause their agglutination. Practically, erythrocyte cross-linking leads to observable cell clumping. Hemagglutination inhibition tests measure the presence of specific antibodies in the sera that inhibit virus-mediated agglutination of erythrocytes. This is a sensitive assay that is affected, however, by both nonspecific hemagglutinins and agglutinin inhibitors present in the serum. Nevertheless, it is a particularly reliable method in influenza surveillance protocols. 26 Fusion proteins present in the envelope of viruses, such as parainfluenza and RSV, allow their entry into cells by triggering fusion of the viral surface with the cell surface membrane. In the case of erythrocytes, fusion may lead to hemolysis. Hemolysis inhibition assays take advantage of these properties to measure the presence of antibodies in a serum sample that bind and block viral antigens and inhibit hemolysis. In this way, the hemolysis inhibition assay detects both antihemagglutinin and antifusion antibodies in the serum. In a typical protocol, serum dilutions are mixed and incubated with purified virus. A 10% suspension of suitable erythrocytes is then added. After some hours of incubation, the erythrocytes are removed by centrifugation and the optical density of the "cleared" supernatant is read with a spectrophotometer. A classic endpoint titer can then be calculated by defining the highest serum dilution that causes 50% inhibition of hemolysis.
In passive agglutination assays, sera are incubated with viral antigens attached to erythrocytes or to materials such as latex or bentonite. The particles or cells agglutinate in the presence of a specific antibody, forming precipitates in the bottom of the tubes. In the passive hemagglutination method, aggregates of erythrocytes develop due to "antibody bridges" formed between antigen-coated erythrocytes. These can be visible, even with the naked eye, and may detect low levels of antibodies.
■ DETECTION OF VIRAL NUCLEIC ACIDS
A constellation of methods that gained increasing attention during recent years due to their increased sensitivity, ease of use, and accuracy are genetic material-based methods, with PCR in the leading position. The common element in these methods is the isolation and partial purification of viral RNA or DNA and its subsequent detection and analysis in suitable molecular biology systems.
Hybridization
Hybridization-based protocols require the presence of singlestranded RNA or DNA. Because the majority of respiratory viruses are single-stranded RNA, these viruses are believed to be suitable for detection with hybridization techniques. In this approach, a suitable oligonucleotide probe sharing a certain degree of homology that allows base pair matching with the single-stranded viral nucleic acid is allowed to anneal under stringent reaction conditions (hybridization). Whereas singlestranded RNA viruses provide ready-made, yet labile, genetic material, the double-stranded DNA content of adenovirus must first be denatured or dissociated by chemical (e.g., sodium hydroxide) or physical (heat) means. The resulting single-stranded DNA would return to its double-stranded configuration on removal of the dissociation agent. The probe can be labeled directly with enzymes or other reporter molecules; alternatively, linker moieties, such as biotin or digoxigenin, can be attached to probes and serve as bridges for the attachment of reporter molecules. Digoxigenin-labeled probes are believed to be more sensitive for in situ hybridization than those using the biotin-streptavidin system. In a typical protocol, the viral nucleic acid is isolated, purified, denatured, and bound to a nitrocellulose or nylon membrane. The probe, denatured and labeled, is incubated with the viral nucleic acid, under carefully defined conditions, and unbound material is thoroughly washed out. A reporter molecule is then added (e.g., alkaline phosphatase-labeled streptavidin), and after a second incubation period, the unbound reporter is washed out and the final chromogen or other suitable substrate is added to give rise to a measurable signal.
Several hybridization-based techniques are used for viral nucleic acid detection, such as the molecular biology dot-blot and Southern blot protocols and liquid and in situ hybridization. As suggested by its name, liquid hybridization allows the detection of nucleic acid that is free in solution rather than attached to a solid-phase surface. Microtiter plates and strips can be used in this method, increasing the ease of handling. In situ hybridization allows the detection of virus in a variety of sources, including cells and tissues grown or fixed on slides, respectively. RNA hybridization proved to be a sensitive method for detecting influenza replication in culture, being clearly superior to hemagglutination assays. 27 It shows high sensitivity in detecting RNA viruses (detection limits, 30-100 copies of viral genome/cell). For example, in situ hybridization-based detection of RV is shown in biopsy specimens from human bronchi ( Fig. 22-2) . In some cases, hybridization can be superior even to PCR in detecting a respiratory virus in the airway. 28 Hybridization techniques are also used in combination with PCR-based methods to increase the overall sensitivity of respiratory virus detection protocols.
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■ FIGURE 22-2. Detection of rhinovirus ribonucleic acid with in situ hybridization, in a bronchial biopsy specimen obtained from a volunteer, (A) at baseline and (B) after experimental inoculation with rhinovirus. No signal could be observed in the baseline biopsy specimen, whereas an intense signal (black spots), located at the bronchial epithelium, is present 3 days after nasal inoculation with the virus.
Polymerase chain reaction methods allow specific amplification of defined DNA sequences and their subsequent detection and assessment. They have become a common practice in detection protocols during the last few years. This section discusses recent innovations in the field, but does not describe PCR basics in detail. Many existing handbooks describe this method. The majority of respiratory viruses are RNA viruses; therefore, reverse transcription PCR is required for their detection in clinical samples. First, total RNA is extracted from NPA samples or throat swabs by standard molecular biologic techniques. The samples should be kept at −70 o C to avoid deterioration of the genetic material. A good practice is to store samples at −70 o C in an appropriate virus transport medium (e.g., Hank's balanced salt solution enriched with 0.5% bovine serum albumin). If throat swabs are the source, they can be placed directly into a denaturing solution to inactivate ribonuclease enzyme activity, and then stored or transported at room temperature. Extracted RNA is then reverse transcribed into complementary DNA (cDNA; e.g., with reverse transcriptase isolated from a retrovirus, such as murine MoMuLV) and further amplified by PCR using virus-specific oligonucleotides (primers) that have been designed with the aid of computer software. These primers are usually planned to amplify sequences that are 100 to 1000 base pairs long (amplicons), and can be designed so that they discriminate between different serotypes of the same virus. Nucleotide diversity that is frequently observed among different strains of a given virus species should also be taken into account, and areas of high homology should be selected for serotype-specific primer pairs design. The amplicons can then be electrophoresed in a 1% to 2.5% agarose gel and visualized as DNA bands under an ultraviolet transilluminator after they are stained with ethidium bromide or another DNA dye. This is readily accomplished within 1 working day, a fact that is of particular importance for the clinical diagnostic laboratory.
To further improve the specificity and sensitivity of the test, the amplicons can be hybridized with labeled synthesized DNA probes directed against regions of the amplicon. For instance, Southern blot has been successfully used for the identification of picornaviruses. Alternatively, reverse transcriptase PCR can be combined with EIA techniques, consisting of hybridization of the amplicon with biotinylated RNA probes directed against the internal sequences of the amplicon. Time-resolved fluorometry has also been combined with PCR for the detection of picornaviruses. 29 PCR amplicons can also be used as a source for a second round of PCR in the "nested" PCR that usually shows increased sensitivity. In this approach, a second set of primers is designed against sequences that were localized internally in the sequences that were amplified in the first round. The method can be so sensitive as to detect a few particles of respiratory virus. 30 Nested-type PCR not only may increase sensitivity, but also may discriminate between serotypes within viral species that are of similar size and thus are difficult to separate with gel from the first round of PCR. Discrimination within or between species can be also accomplished by digesting the amplicons with restriction endonucleases. Human RVs, for instance, can be discriminated from enteroviruses based on the specific pattern produced after digestion of the PCR product with BglI restriction endonuclease. 31 Enteroviruses lack a BglI recognition site in their respective amplified sequence. Thus, their product remains undigested, retaining its original size ( Fig. 22-3) .
In multiplex PCR, a mix of primer pairs is used, allowing simultaneous amplification and detection of several serotypes or viruses. There are many such examples in the literature; the formulation of Hexaplex (Prodesse, Waukesha, Wisconsin), for instance, allows the detection of H1N1, H3N2, influenza A, influenza B, both RSV subtypes, and three of the four human parainfluenzas. 32 This multiplex PCR has been tested in clinical samples and seems to achieve high rates of sensitivity and specificity. In addition, this highly sensitive and rapid type of test not only allows simultaneous detection of many viruses, providing obvious advantages for clinical practice, but also may reveal the presence of virus in samples with few viral copies or the presence of viral RNA without live virus, both of which may be missed with conventional cell culture techniques. The detection limits of multiplex reverse transcriptase PCR protocols allow the identification of as few as 100 to 140 copies of virus/mL, or one TCID 50 . This method can be at least as sensitive as combined tissue culture and immunofluorescence methods. Combination with hybridization may further improve detection scores. In a combination of multiplex reverse transcriptase PCR and enzyme hybridization assay, the amplicons of seven respiratory viruses (RSV A and B, influenza A and B, parainfluenza 1-3 viruses) were purified and hybridized with peroxidase-labeled probes into avidin-coated, 96-well microplates. The signal emitted after incubation of the complex with the substrate allowed the detection of almost twice as many positive clinical samples compared with conventional culture and indirect immunofluorescence methods. 33 The performance of multiplex PCR assays may vary, depending on the virus tested. For instance, a multiplex PCR enzyme-linked immunosorbent assay that can detect seven respiratory viruses, in addition to the common respiratory pathogens Mycoplasma pneumoniae and Chlamydia pneumoniae, although it proved to be more sensitive than cell culture in detecting parainfluenza 3 virus, adenovirus, and influenza virus, was less efficient (by at least a factor of 10) in revealing RSV and parainfluenza 1 virus. Recent developments in this method include primers specific for additional viral and bacterial species (e.g., Reovirus, Bordetella pertussis), allowing for the detection of as many as 19 different microorganisms in a clinical sample. 34 Finally, multiplex PCR assays have been designed to discriminate between multiple subtypes within one species, as is the case with adenoviruses and picornaviruses. 35, 36 In another approach, degenerate primers have been used to discriminate between adenovirus serotypes. 37 Amplicons can also be subjected to sequence analysis to identify potential point mutations or deletions or specific serotypes. Cloning of PCR fragments that are generated with a series of partially overlapping or degenerate primers into bacterial plasmids allows sequencing of the entire viral genome, a laborious activity that is not necessary for usual clinical practice, but is indispensable when a previously unknown viral species is characterized (e.g., MPV) or when a high-risk epidemic from an initially unknown viral strain or mutation must be confronted efficiently and quickly (e.g., SARS). Heteroduplex formation between the amplicons may result in differential mobility of the product when run in a gel, and can be used for subtyping viral genomes. By combining, for instance, reverse transcriptase PCR and heteroduplex formation, variant strains of influenza can be differentiated. 38 In situ PCR allows detection of viral genetic material and, furthermore, its localization at the cellular and tissue levels, providing information that is of particular importance for clinical pathology. Thus, paraffin-embedded, fixed cells or tissue sections are xylene-treated and then digested with protease and deoxyribonuclease solutions. The PCR mixture containing Taq polymerase is placed on top of it, and the entire slide is placed on an aluminium foil boat, transferred onto a conventional or modified PCR apparatus, and subjected to PCR amplification. If the one of the four deoxynucleoside 5′-triphosphates (dNTPs) that is present in the PCR mixture and is providing the nucleotide source is reduced and replaced by a modified nucleotide (e.g., biotinylated or digoxigenin-coupled deoxyuridine 5-triphosphate), then the emerging amplicons can be detected by incubation with an enzyme-labeled probe (e.g., alkaline phosphatase, antidigoxigenin). Alternatively, in the absence of modified nucleotides, the amplified DNA can be detected by conventional in situ hybridization, conducted as described earlier. Alternatively, the PCR mixture can be transferred to a test tube and run in an agarose gel or subjected to Southern analysis to identify the viral genomic fragments.
Real-Time Polymerase Chain Reaction
Recent advances in PCR technology allowed the development of real-time PCR. Real-time PCR can be more sensitive and timeefficient than conventional PCR, cell culture, and immunofluorescence in detecting respiratory viruses in clinical samples 39, 40 ; further, it is quantitative, allowing for assessment of the exact number of viral copies in a clinical sample. This is of particular importance because, in some cases, the actual viral load may determine the course of a disease. The final detection step employs either a dye able to bind to double-stranded DNA (e.g., SYBR Green I) or a more specific hybridization probe (e.g., TaqMan, Molecular Beacons, Light Cycler probes) to monitor the presence and quantity of amplicons. For quantitative analysis as well as determination of the detection limits, serial dilutions of plasmid DNA containing a known amount of viral genome (virus genome equivalent) per microliter can be used as a standard reference solution.
In fluorescent dye SYBR Green protocols, the dye is incorporated into the amplicons in each cycle and assessment of fluorescing DNA is collected during each extension phase. However, such dyes bind to DNA, independent of the specific sequence, and thus can also detect undesired, nonspecifically amplified DNA. Thus, the specificity of the method is tested by the melting curves at which the final amplicon is briefly heated to denature (e.g., 95 o C), allowed to reassociate at a lower temperature (e.g., 65 o C for 15 seconds), and finally re-denatured to 95 o C by gradually increasing the temperature at a defined rate (e.g., 0.1 o C/sec). The continuously measured fluorescence data recorded during this last stage are plotted against the temperature and allow calculation of the melting peak that characterizes a given amplicon under the conditions used. When the melting peak of a particular product coincides with the standard, it is considered specific. Highly sensitive one-and two-step, real-time PCR assays for the qualitative and quantitative detection of most respiratory viruses, including SARS-CoV, have been reported. [41] [42] [43] In hybridization-based protocols, a specific probe sharing consensus homology with the sequenced strains of a viral species is labeled with a reporter fluorogenic dye (e.g., 6-carboxyfluoroscein) at the 5′ end and a quencher dye (e.g., carboxytetramethylrhodamine) at the 3′ end. The probe is present in the conventional PCR master mix (containing buffer, magnesium +2 salts, dNTPs, water, and the primers) during PCR, and the real-time apparatus records the fluorescence emerging during time. The reporter dye fluorescence (e.g., 6-carboxyfluoroscein) is considered positive and compared with the fluorescence emitted by a reference dye present in the PCR master mix to normalize for non-PCR-related fluorescence fluctuations among samples. A threshold is usually set, above which a signal is considered positive.
Recent approaches to the detection of respiratory viruses include the development of multiplex real-time PCR protocols. A SYBR Green-based reaction, for instance, allowed simultaneous detection of influenza A and B, together with RSV, with specificity comparable to that achieved with commercially available rapid antigenic tests and considerably higher sensitivity scores. 44 Discrimination between the particular species was based on the specific melting temperature curves elicited by the amplicons. This method, however, was not designed to discriminate between A and B subtypes of RSV. Limitations in the number of viruses and viral serotypes are inherent in the real-time approach, especially in the protocols using a labeled probe, because most platforms do not allow the simultaneous use of more than two fluorochromes. Using a more advanced apparatus that can detect up to four fluorochromes, Templeton and colleagues 45 succeeded in detecting both influenza serotypes, RSV, and all four parainfluenza subtypes in a two-tube reaction. In their approach, the specific probes were labeled with different fluorochromes (i.e., 6-carboxyfluoroscein, Texas red, hexachlorofluoroscein, and cyanin 5); the overall reaction could be accomplished within 6 hours and proved to be more sensitive than cell culture in detecting these seven respiratory viruses in clinical samples. The detection limits ranged from 0.1 to 0.0001 TCID 50 of viral stocks of known titer, depending on the virus.
Other Methods
Advances in molecular biology continuously offer additional PCR-and hybridization-based methods. In a recent study, as few as 100 RNA copies of parainfluenza virus (or one TCID50) could be detected by probe hybridization and electrochemiluminescence or by using molecular beacons. 46 The first step in this approach, nucleic acid sequence-based amplification, was used. This technique employs avian myeloblastosis virus reverse transcriptase, together with ribonuclease H and T7 RNA polymerase, under isothermal conditions, and is able to directly amplify RNA. The use of nucleic acid sequences to amplify RNA with primers directed against the 5′ noncoding region of RV serotypes allows discrimination between RV subgroups. 47 Complementary DNA-amplified restriction fragment length polymorphism allows the identification of previously unknown viral sequences. In this method, double-stranded cDNA is synthesized from viral RNA and digested with frequently cutting restriction endonucleases. Double-stranded adaptors are then ligated to the ends of the emerging restriction fragments and provide primer sites during PCR amplification. A second selective fragment amplification step is conducted by adding one or more bases to the PCR primers. If the complementary bases are present in the viral sequence, then successful amplification will occur. A modification of this method was successfully employed in the recent discovery of the new coronavirus NL63. 10 Recently, Wang and colleagues used the powerful microarray technology to detect approximately 140 distinct viral genomes simultaneously, including most respiratory viruses. 48 To that end, 1600 oligonucleotides with a relatively greater length than those commonly used in array technology (70 vs. 20-25 bases) were selected after a genome-wide BLAST (Basic Local Alignment Search Tool, a method for rapid searching of nucleotide and protein databases) analysis and ranked according to shared homology to regions of the viral genomes. Using an ink-jet oligonucleotide synthesizer, these oligonucleotides are synthesized in situ and placed onto directed locations of a glass wafer. 49 The glass surfaces can then be hybridized, under strict conditions, with cDNA, PCR amplicons, RNA, or another form of genetic material derived from viral stocks, virally infected cells in cultures, or clinical samples. Human and cellular transcripts are also included to normalize against nonspecific hybridization. This material is labeled with cyanin 5 or cyanin 3, which provides red or green coloring, respectively, to allow color visualization of microarray data that are obtained after the arrays are scanned with confocal laser scanners and analyzed with suitable instrumentation and software. This method allows the detection of paramyxoviruses, orthomyxoviruses, adenoviruses, and picornaviruses from clinical samples. It can also detect and discriminate among all 102 RV serotypes, based on the hybridization pattern obtained from each serotype. After human volunteers were experimentally infected with RV, the array could detect as few as 100 infectious RV particles in NPA samples. 48 Analysis of a small number of samples from naturally acquired colds showed different RV serotypes and parainfluenza 1 virus, which has also been confirmed by conventional reverse transcriptase PCR. Although it is extremely promising, this technique needs further evaluation, including cost-effectiveness, before being applied in clinical practice.
Practical Considerations in the Use of Nucleic Acid-Based Techniques
Nucleic acid-based virus detection is both rapid and accurate. The identification of a particular virus can be further, and without doubt, confirmed by restriction analysis or sequencing of the product and further comparison with published genome databases. In addition, the PCR-based methods have proved to be very sensitive, usually exceeding the sensitivity scores of cell culture techniques. However, false-positive or false-negative findings can be a problem with these methods, if certain practical measures in the handling of viral genetic material are not meticulously followed. First, preservation of the sample is of particular importance for the integrity of the viral genomic material. RNA, the genomic material of most respiratory viruses, is particularly vulnerable to degradation by ribonucleases that are present in all biologic samples and fluids. Ribonuclease-free vials, solutions, and buffers should be used in designated areas of the laboratory, and all material should be used by specialized personnel. In addition, if it takes too long for an NPA sample to be transported from the clinic to the laboratory, or if the sample remains on ice for too many hours instead of being placed in the freezer immediately, the sensitivity of the method, even that of a PCR-based protocol, can be unexpectedly low. Further, biologic fluids often contain substances that can inhibit PCR amplification (e.g., mucus). In this case, dilution of the sample or treatment with a suitable agent (e.g., dimethyl sulfoxide) may facilitate detection of the virus. The use of clinical samples spiked with stock virus or the inclusion of synthetic heterologous competitor RNA in the reaction may facilitate normalization of PCR outcomes.
On the other hand, PCR-based techniques are also subject to problems with contamination, especially if large numbers of samples are handled simultaneously. In the case of a nested PCR protocol, the first and second rounds of PCR should be conducted in separate areas, with separate sets of pipettes, and of course, with different plasticware. Nested PCR protocols include several negative controls to monitor for the presence of contamination. If it occurs, replacement of the pipettes is required, as well as a review of laboratory and handling practices.
■ TECHNIQUES TO DIAGNOSE RESPIRATORY VIRUSES IN CLINICAL PRACTICE
Respiratory infections cause a major health problem, with huge associated costs and mortality rates worldwide. In addition, threatening influenza pandemics and mortal epidemics of previously unknown respiratory viruses, such as SARS-CoV, require the use of rapid and reliable detection methods in clinical practice. Moreover, large epidemiologic studies are required to better define the involvement of these viruses in noninfectious diseases, such as asthma, in the short and long term. This analysis will help in drug development and the implementation of intervention strategies, even during an outbreak. Because many respiratory symptoms are common among these viruses, clinical examination does not determine the etiology of particular cases. On the other hand, drugs are being developed that specifically block infection by individual viruses (i.e., anti-influenza neuraminidase inhibitors), but they are useless if the patient has been infected by another virus. Thus, all of these methods are of major and increasing importance and use in clinical practice. It is not possible to determine which is the optimal method for virus detection because many parameters vary, depending on the particular conditions and the scope of the analysis (cost-effectiveness, time required, sensitivity, availability of skilled personnel and laboratory equipment). It is a combination of methods, rather than a single one, that is practically used in particular cases because most protocols are not ideal. Even electron microscopy is still recognized as an indispensable method in some cases. 50 Although cell culture remains the gold standard, it is time consuming and tends to be replaced by antigen-detecting methods and molecular biologic techniques. Their commercial availability, ease of performance, and rapidity have made the newly developed antigenbased methods increasingly popular. Actually, these tests tend to be preferred in routine analysis, especially in small units lacking advanced facilities. They can be accomplished within 15 minutes to a few hours. However, they can be inferior to cell culture in terms of sensitivity, 51 and are of limited value for the detection of some respiratory viruses, such as RSV, in older population groups. 52 ■■■ CHAPTER 22
DIAGNOSIS OF VIRAL RESPIRATORY ILLNESS: PRACTICAL APPLICATIONS
On the other hand, PCR has been widely used as a research tool during the last decade, and its clinical use is steadily increasing. PCR cannot, however, replace the use of cell culture in worldwide influenza surveillance, an aspect of classic virology that is vital for informing vaccine constituents. 53 
■ FUTURE DIRECTIONS
Rapidity, high sensitivity and specificity, ease of use, and costeffectiveness are the major requirements imposed on the respiratory viral detection assay field. In particular, the need for rapid diagnostics is likely to increase as more specific antiviral therapies enter the market. Many of the whole-virus, antigen, serologic, and molecular methods have been extensively tested and used in clinical practice. Although PCR-based analysis was the major breakthrough in recent years, none of the existing methods can be considered ideal, and usually, a combination of techniques is used for more accurate results, increasing the costs, time, and skills required for analysis. Rapid antigen detection tests are, for the moment, the easiest to apply and are expected to be further improved in the future. Electronic microscopy is still useful in many cases, as, for example, in the crucial first screening and characterization of the previously unknown SARS-CoV.
Simultaneous and reliable detection of as many viruses as possible, in the shortest time possible, and ideally, in a single test, is the goal of any novel and future technique. Although it is specific, sensitive, and reliable, multiplex real-time PCR can detect only limited numbers of viruses simultaneously. This may, however, improve in the future. Nevertheless, detection of up to 19 microorganisms seems to be achievable with conventional multiplex PCR methods, retaining PCR approaches in a leading position. On the other hand, the rapidly developing gene array field is promising, but without clinical relevance. This technique can also be combined with assays revealing expression patterns of target genes in the host, thus providing an overall picture not only of viral presence, but also of host response. This pattern could provide additional information regarding the immediate effects of a specific treatment that would obviously be of tremendous importance in clinical practice.
